Neuroinflammation as a common feature of neurodegenerative disorders

L Guzman-Martinez, RB Maccioni, V Andrade… - Frontiers in …, 2019 - frontiersin.org
Neurodegenerative diseases share the fact that they derive from altered proteins that
undergo an unfolding process followed by formation of β-structures and a pathological …

Glutathione metabolism and Parkinson's disease

M Smeyne, RJ Smeyne - Free Radical Biology and Medicine, 2013 - Elsevier
It has been established that oxidative stress, defined as the condition in which the sum of
free radicals in a cell exceeds the antioxidant capacity of the cell, contributes to the …

[HTML][HTML] Arizona study of aging and neurodegenerative disorders and brain and body donation program

TG Beach, CH Adler, LI Sue, G Serrano… - … : official journal of the …, 2015 - ncbi.nlm.nih.gov
Abstract The Brain and Body Donation Program (BBDP) at Banner Sun Health Research
Institute (http://www. brainandbodydonationprogram. org) started in 1987 with brain-only …

Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of …

K Burgos, I Malenica, R Metpally, A Courtright… - PloS one, 2014 - journals.plos.org
The discovery and reliable detection of markers for neurodegenerative diseases have been
complicated by the inaccessibility of the diseased tissue-such as the inability to biopsy or …

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

G Morris, M Berk, AF Carvalho, M Maes… - Behavioural brain …, 2018 - Elsevier
Ferroptosis is a unique form of programmed death, characterised by cytosolic accumulation
of iron, lipid hydroperoxides and their metabolites, and effected by the fatal peroxidation of …

Glutathione transferases and neurodegenerative diseases

AP Mazzetti, MC Fiorile, A Primavera… - Neurochemistry …, 2015 - Elsevier
There is substantial agreement that the unbalance between oxidant and antioxidant species
may affect the onset and/or the course of a number of common diseases including …

3‐hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis

PA LeWitt, J Li, M Lu, TG Beach, CH Adler… - Movement …, 2013 - Wiley Online Library
Parkinson's disease (PD) biomarkers are needed to enhance therapeutics research and to
understand PD pathogenesis. Methods that simultaneously measure hundreds of small …

Submandibular gland needle biopsy for the diagnosis of Parkinson disease

CH Adler, BN Dugger, ML Hinni, DG Lott… - Neurology, 2014 - AAN Enterprises
Objective: This study investigates salivary gland biopsies in living patients with Parkinson
disease (PD). Methods: Patients with PD for≥ 5 years underwent outpatient transcutaneous …

Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease

R Jiang, C Rong, R Ke, S Meng, X Yan, H Ke, S Wu - Medicine, 2019 - journals.lww.com
Exosomes are nanometer-sized vesicles with intercellular communication functions, and
their encapsulated proteins may participate in the pathological process of …

Cerebrospinal fluid biomarkers for P arkinson's disease–a systematic review

AD Andersen, M Binzer, E Stenager… - Acta Neurologica …, 2017 - Wiley Online Library
Diagnosis of Parkinson's disease (PD) relies on clinical history and physical examination,
but misdiagnosis is common in early stages. Identification of biomarkers for PD may allow …